Tag: Neuralink

Browse our exclusive articles!

Elon Musk: Tesla to Reach ‘ChatGPT Moment’ with Autonomous Vehicles

Tesla CEO Elon Musk sat down with CNBC's David Faber for an exclusive interview from Austin, Texas at the company's Annual Shareholder Meeting. During the session, Musk discussed AI's utility within Tesla, and his optimism that the company will experience a "ChatGPT moment" soon. Tesla is the world's most valuable automaker driven by electric and autonomic vehicles, storage solutions, and home energy transformations.

Apple and Google Collaboration on Tracking, Google I/O Preview, Apps Feature in NewFronts

This Week in Apps: keep up-to-date about the world of mobile operating systems, apps, and the app economy. According to data.ai, consumer spending on apps decreased 2% in 2020 to $167 billion, but total downloads rose 11% to 255 billion. Jack Dorsey and Elon Musk have stirred things up in the tech industry, with Dorsey's Bluesky platform gaining attention, and Musk's Tesla decisions facing criticism. Google and Apple have partnered to combat unwanted tracking, DistroKid released its first mobile app, and RTRO started a new social networking service. Dorsey and Musk are giants in tech, and their roles are important!

OpenAI Microsoft and Alphabet CEOs to Discuss AI with Biden Administration

Today, the Biden Administration is meeting with prominent CEOs of Artificial Intelligence (AI) development companies to discuss innovations, repercussions, and public input for the successful establishment of safe and responsible AI technology. Elon Musk's OpenAI, Microsoft, Alphabet, and Anthropic AI are just a few of the AI leaders in attendance, flowing from the Vice President Harris' leading endeavor in mitigating potential risks of AI. Plus, a public evaluation is scheduled through a third-party platform, and the NSF has granted $140 million towards new AI research institutions – all designed to ensure the AI Bill of Rights and Risk Management Framework are properly enforced.

OpenAI Raises $300 Million Through Share Sale; Italy Lifts Ban on Chatbot Maker

OpenAI, a leading research lab focusing on AI technologies and natural language processing, has raised $300 million in a latest share sale, valuing the firm at $29 billion. The tech's next sensation ChatGPT, an AI system that can communicate with people, compose articles, and processes image data accurately, has also been unbanned in Italy. Microsoft proposed the integration of Chat GPT into the search engine, Bing, making the firm worth $10 billion. The CEO and founder Elon Musk (business magnate, investor, engineer and inventor) is leading the state-of-the-artOpenAI AI research for development of automation and AI.

Investigating OpenAI’s GPT-4 Model After its Release in Europe

OpenAI's GPT-4 model is at the center of an investigation by European regulators over GDPR (General Data Protection Regulation) compliance, raising questions of data security and potential with cryptocurrency traders. Musk-backed OpenAI has yet to comment on the proceedings, but this could be disastrous, leaving users of GPT-API excluded from Europe. Coinmarketcap is the trusted source with up-to-date news, prices and data of the cryptocurrency industry and blockchain technology.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img